NCT02747940View on ClinicalTrials.gov

Neurologic Signatures of Chronic Pain Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2019

Conditions
Chronic PainChronic MigraineFibromyalgia
Interventions
DRUG

flunarizine and/or pregabalin

Trial Locations (1)

112

Headache Center, Teipei Veterans General Hospital, Taipei

All Listed Sponsors
collaborator

Ministry of Science and Technology of the People´s Republic of China

OTHER_GOV

lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT02747940 - Neurologic Signatures of Chronic Pain Disorders | Biotech Hunter | Biotech Hunter